All In Biotech

Free tool

FAERS Monitor: Neurolite

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020256 or its brand name (Neurolite, Technetium Tc-99m Bicisate Kit). Reports on generic versions are filed under their own applications.

Reports

23

Serious

11

48% of reports

Hospitalization

7

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective8
  • product preparation error5
  • radioisotope scan abnormal3
  • adverse event1
  • anaemia1
  • anaphylactic shock1
  • arthralgia1
  • blood pressure decreased1
  • chills1
  • cholecystitis1
  • cholelithiasis1
  • cold sweat1
  • confusional state1
  • decreased appetite1
  • depression1

Reports by year received

View as table
YearReports
20043
20073
20081
20101
20162
20172
20182
20201
20213
20224
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,136 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
radioisotope scan abnormalSignal33900.81354.48,088
product preparation errorSignal5222.6102.5893
cholecystitis176.811.318
cold sweat151.97.612
anaphylactic shock135.55.28
cholelithiasis127.94.16
blood pressure decreased113.82.03
adverse event19.91.52
chills17.81.11
confusional state15.70.81
drug ineffectiveSignal85.63.227
anaemia14.80.70
depression14.00.60
decreased appetite13.90.60
arthralgia12.20.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.